Esophageal Stents Market by Type, Material, Application, End User

List of Tables

[189 Pages Report] The Esophageal Stents Market size was estimated at USD 150.40 million in 2023 and expected to reach USD 159.47 million in 2024, at a CAGR 6.26% to reach USD 230.10 million by 2030.

Esophageal stents are tubular devices made of metal or plastic that are used to open narrowed areas of the esophagus, the tube that carries food from the throat to the stomach. These stents are primarily used to treat esophageal strictures or blockages, often caused by cancer, gastroesophageal reflux disease (GERD), or other medical conditions. The growing prevalence of esophageal cancer advances in stent technology that improves patient comfort and outcomes and the minimally invasive nature of stent placement compared to traditional surgical procedures have expanded the use of esophageal stents. Despite their benefits, esophageal stents can cause complications, such as migration, where the stent moves from its original position or re-obstruction caused by tumor growth through the stent. Additionally, patients may experience discomfort or pain, particularly when swallowing. Addressing these issues involves continuous improvements in stent design, such as developing biodegradable stents that dissolve over time, reducing the need for additional procedures, or coating stents with drugs to help combat tumor growth. Nevertheless, increasing research into stent materials and coatings that enhance compatibility with the body and reduce complications provides added growth for the market. There is also potential in customizing stents for patients based on personalized medical needs, leveraging advances in 3D printing technology.

KEY MARKET STATISTICS
Base Year [2023]	USD 150.40 million
Estimated Year [2024]	USD 159.47 million
Forecast Year [2030]	USD 230.10 million
CAGR (%)	6.26%

Regional Insights

In the Americas, U.S., and Canada, there is a high adoption rate of advanced medical technologies, which includes the use of esophageal stents for conditions including esophageal cancer and benign esophageal strictures. The market is supported by well-established healthcare infrastructure and favorable reimbursement policies. Moving to EMEA, Europe leads in terms of market maturity, especially in countries such as Germany, France, and the UK, which are driven by increasing healthcare expenditure and the prevalence of esophageal diseases. The Middle East and Africa are gradually catching up, although the market growth here is tempered by varying levels of healthcare access and economic constraints. The Asia Pacific region showcases significant growth potential, particularly in countries such as China, Japan, and India. This growth is spurred by rising healthcare standards, an increasing middle-class population, and growing medical tourism.

Market Insights

Market Dynamics

The market dynamics represent an ever-changing landscape of the Esophageal Stents Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers
- Increasing global incidence of esophageal cancers and gastrointestinal diseases
- Growing consumer preference for minimally invasive surgeries

Market Restraints
- Product recalls and economic accessibility of esophageal stents

Market Opportunities
- Ongoing advancements in esophageal stents for better outcomes
- Rise in government approvals for new developments

Market Challenges
- Product compatibility and standardization in esophageal stents

Market Segmentation Analysis
- Type: Growing preference for biodegradable stents for short-term intervention
- End User: Emerging need of broad spectrum of stent specifications from hospitals to manage more complex cases

Market Disruption Analysis
Porter's Five Forces Analysis
Value Chain & Critical Path Analysis
Pricing Analysis
Technology Analysis
Patent Analysis
Trade Analysis
Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Esophageal Stents Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Esophageal Stents Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Olympus Corporation Advances in Gastrointestinal Treatment Through Acquisition of Taewoong Medical

Olympus Corporation finalized its acquisition of Taewoong Medical Co., Ltd., a South Korean firm renowned for its advanced gastrointestinal metallic stents. This strategic move, valued at approximately USD 370 million, integrates Taewoong Medical into Olympus' Therapeutic Solutions Division, enhancing its capabilities in the GI EndoTherapy arena. This acquisition fortifies Olympus's portfolio in providing comprehensive GI solutions and aims to elevate patient care standards globally. [Published On: 2024-01-24]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Esophageal Stents Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Esophageal Stents Market, highlighting leading vendors and their innovative profiles. These include Advin Healthcare Private Limited, Boston Scientific Corporation, Changzhou Health Microport Medical Device Co., LTD., Cook Group Incorporated, ELLA-CS, s.r.o., ENDO-FLEX GmbH. by Medi-Globe Group, Leufen Medical by bess AG., M.I.TECH., Medorah Meditek Pvt. Ltd., Medtronic plc, Merit Medical Systems, Inc., MICRO-TECH (Nanjing) Co., Ltd., Micro-Tech Endoscopy, Mitra Industries Pvt. Ltd., Olympus Corporation, S&G Biotech Inc., TAEWOONG MEDICAL Co., Ltd, and W. L. Gore & Associates, Inc..

Market Segmentation & Coverage

This research report categorizes the Esophageal Stents Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
- Biodegradable Stents
- Self-expandable Metal Stents
- Self-expandable Plastic Stents

Material
- Nitinol
- Silicone
- Stainless Steel

Application
- Benign Strictures
- Malignant Strictures

End User
- Ambulatory Surgical Centers
- Hospitals

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam

Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom

Product Code: MRR-5D693B46C01D

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Increasing global incidence of esophageal cancers and gastrointestinal diseases
  - 5.1.1.2. Growing consumer preference for minimally invasive surgeries
- 5.1.2. Restraints
  - 5.1.2.1. Product recalls and economic accessibility of esophageal stents
- 5.1.3. Opportunities
  - 5.1.3.1. Ongoing advancements in esophageal stents for better outcomes
  - 5.1.3.2. Rise in government approvals for new developments
- 5.1.4. Challenges
  - 5.1.4.1. Product compatibility and standardization in esophageal stents
5.2. Market Segmentation Analysis
- 5.2.1. Type: Growing preference for biodegradable stents for short-term intervention
- 5.2.2. End User: Emerging need of broad spectrum of stent specifications from hospitals to manage more complex cases
5.3. Market Disruption Analysis
5.4. Porter's Five Forces Analysis
- 5.4.1. Threat of New Entrants
- 5.4.2. Threat of Substitutes
- 5.4.3. Bargaining Power of Customers
- 5.4.4. Bargaining Power of Suppliers
- 5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis

6. Esophageal Stents Market, by Type

6.1. Introduction
6.2. Biodegradable Stents
6.3. Self-expandable Metal Stents
6.4. Self-expandable Plastic Stents

7. Esophageal Stents Market, by Material

7.1. Introduction
7.2. Nitinol
7.3. Silicone
7.4. Stainless Steel

8. Esophageal Stents Market, by Application

8.1. Introduction
8.2. Benign Strictures
8.3. Malignant Strictures

9. Esophageal Stents Market, by End User

9.1. Introduction
9.2. Ambulatory Surgical Centers
9.3. Hospitals

10. Americas Esophageal Stents Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Esophageal Stents Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Esophageal Stents Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
- 13.3.1. Olympus Corporation Advances in Gastrointestinal Treatment Through Acquisition of Taewoong Medical
13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

14.1. Key Company Profiles
14.2. Key Product Portfolio